Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
FTC Wants To Break Up JUUL, Altria After Discovering E-Cigarette Non-Competition Clause May 28, 2020 Irvin Jackson Add Your CommentsFederal regulators want to end the tobacco giant Altriaโs investment in the leading vape manufacturer, JUUL Labs, indicating that the agreement between the two companies violates antitrust laws.An administrative complaint (PDF) was filed last month by the Federal Trade Commission (FTC), after investigators discovered Altria made a secret agreement to stop competing against JUUL in the e-cigarette market, in return for a massive investment in the vape pen manufacturer.Altria Group is one of the worldโs largest tobacco companies, and made a controversial $12.8 billion investment in JUUL Labs, Inc. in December 2018, acquiring a 35% stake in the market-leader for e-cigarette products.LEARN MORE ABOUTVAPE PEN AND E-CIG LAWSUITSSerious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONLearn More AboutVAPE PEN AND E-CIG LAWSUITSSerious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONโFor several years, Altria and JUUL were competitors in the market for closed-system e-cigarettes. By the end of 2018, Altria orchestrated its exit from the e-cigarette market and became JUULโs largest investor,โ Ian Conner, Director of the Bureau of Competition, said in an FTC press release. โAltria and JUUL turned from competitors to collaborators by eliminating competition and sharing in JUULโs profits.โThe deal included not only an agreement that Altria would not compete against JUUL for six years, but also allowed Altria to appoint an observer to JUULโs Board of Directors, and would also have let Altria appoint three members to JUULโs Board after its shares were converted to voting securities.In September 2019, JUULโs previous CEO was forced to step down amid increasing pressure over claims the company marketed its products to children, resulting in a teen vaping and nicotine addiction epidemic. The CEO was replaced by the Altria executive who was originally only supposed to be an observer.The FTCโs lawsuit alleges the agreement represents an unreasonable restraint of trade and lessened competition in violation of federal law. The FTC voted 5-0 to file the complaint.JUUL LawsuitsIn addition to the FTC complaint, hundreds of JUUL lawsuits are being pursued by individuals who have now developed life-long nicotine addictions, which were allegedly caused by false and misleading advertisements for the vaping pods that targeted teens and prior non-smokers. In addition, a number of school districts are also pursuing claims for damages that resulted from the vaping epidemic, which has disrupted classes and have diverted resources in recent years.Given similar questions of fact and law presented in claims filed throughout the federal court system, about 600 lawsuitsย are currently centralized before U.S. District Judge William H. Orrick III in the U.S. District Court for the Northern District of California, which is where JUUL Labs, Inc.โs San Francisco headquarters are located.As JUULing addiction lawyers continue to review and file claims for teens and young adults in the coming months and years, the litigation is expected to continue to grow, likely to include thousands of complaints against the manufacturer fo the controversial vaping pod.As part of the consolidation into a MDL, it is expected that Judge Orrick will establish a โbellwetherโ process, where a small group of representative claims will be prepared for early trial dates to help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation. However, if the manufacturer fails to reach JUUL settlements or another resolution for the claims following the consolidated pretrial proceedings, each individual case may be remanded back to U.S. District Courts nationwide for individual trials in the future. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Altria, Antitrust, Children, Drug Addiction, E-Cigarettes, Electronic Cigarettes, FTC, Juul, Nicotine, VapingMore JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Boston Scientific Stimulator Lawsuits Centralized in Federal MDL (Posted: today)Federal regulators have centralized at least 23 Boston Scientific spinal cord stimulator lawsuits in a multidistrict litigation that excludes multiple similar claims involving Abbott and Nevro implants.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITLawsuit Indicates Spinal Cord Stimulator Lead Complications Resulted in Shocks, Removal Surgery (06/02/2026)Spinal Cord Stimulator Malpractice Lawsuit Claims Device Left Veteran Partially Paralyzed (05/29/2026)Abbott Spinal Cord Stimulator Problems Resulted in Severe Paralysis: Lawsuit (05/19/2026) Depo-Provera Meningioma Side Effects Left Woman With Debilitating Migraines, Lawsuit Claims (Posted: 3 days ago)A Depo-Provera meningioma lawsuit indicates that a woman suffered permanent and debilitating injuries after needing to have a brain tumor surgically removed.MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Caused Meningioma 29 Years After First Birth Control Shots: Lawsuit (05/22/2026)Depo-Provera Lawsuit Filings Exceed 6,000, As Court Prepares for First Test Trials (05/18/2026)Intracranial Meningioma from Depo-Provera Shots Caused Hearing Loss, Vision Loss: Lawsuit (05/12/2026) Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects (Posted: 4 days ago)Regeneron and Sanofi-Aventis face a Dupixent injection lawsuit from a Louisiana woman who says the companies knew about the drug’s risks but downplayed them to doctors and patients.MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Claims Eczema Drug Caused Womanโs CTCL Diagnosis (05/28/2026)Link Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges (05/11/2026)Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy (05/01/2026)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Boston Scientific Stimulator Lawsuits Centralized in Federal MDL (Posted: today)Federal regulators have centralized at least 23 Boston Scientific spinal cord stimulator lawsuits in a multidistrict litigation that excludes multiple similar claims involving Abbott and Nevro implants.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITLawsuit Indicates Spinal Cord Stimulator Lead Complications Resulted in Shocks, Removal Surgery (06/02/2026)Spinal Cord Stimulator Malpractice Lawsuit Claims Device Left Veteran Partially Paralyzed (05/29/2026)Abbott Spinal Cord Stimulator Problems Resulted in Severe Paralysis: Lawsuit (05/19/2026)
Depo-Provera Meningioma Side Effects Left Woman With Debilitating Migraines, Lawsuit Claims (Posted: 3 days ago)A Depo-Provera meningioma lawsuit indicates that a woman suffered permanent and debilitating injuries after needing to have a brain tumor surgically removed.MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Caused Meningioma 29 Years After First Birth Control Shots: Lawsuit (05/22/2026)Depo-Provera Lawsuit Filings Exceed 6,000, As Court Prepares for First Test Trials (05/18/2026)Intracranial Meningioma from Depo-Provera Shots Caused Hearing Loss, Vision Loss: Lawsuit (05/12/2026)
Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects (Posted: 4 days ago)Regeneron and Sanofi-Aventis face a Dupixent injection lawsuit from a Louisiana woman who says the companies knew about the drug’s risks but downplayed them to doctors and patients.MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Claims Eczema Drug Caused Womanโs CTCL Diagnosis (05/28/2026)Link Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges (05/11/2026)Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy (05/01/2026)